(lp0
S'Revenue Approximations Analysis: Catalyst Pharmaceuticals, Inc. , Live ... StockNewsJournal - 15 hours ago ROI deals with the invested cash in the company and the return the investor realize on that money based on the net profit of the business.'
p1
aS"Financials of Aurinia Pharmaceuticals and Catalyst Pharmaceuticals are Getting ... Yahoo Finance - Mar 21, 2017 After hours trading showed a continued rise in the company's stock price. Catalyst Pharmaceuticals is a biopharmaceutical company that is currently focused on the development of innovative treatments dealing with rare neuromuscular and neurological&nbsp;..."
p2
aS'Catalyst Pharma shares jump 22% premarket on news of positive trial results ... MarketWatch - Mar 15, 2017 Shares of Catalyst Pharmaceuticals Inc. CPRX, +1.99% jumped 22% in premarket trade Wednesday, after the biotech reported positive data from a trial of a treatment for a form of myasthenia gravis, a rare neuromuscular disease, for which there is ...Catalyst Pharma positive trial data of a treatment for a rare neuromuscular ... - Proactive Investors USA & CanadaCatalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2016 Financial ... - GlobeNewswire '
p3
aS'Catalyst Pharmaceuticals: Why This $1 Biotech Stock Is A Strong Buy For 2017 Seeking Alpha - Jan 4, 2017 I have recently found a couple of very interesting investment opportunities that offer an excellent risk to reward ratio and one of the stocks I am bullish on now is Catalyst Pharmaceuticals, Inc. . As we can see from the chart below, 2016 ...'
p4
aS'Catalyst Pharma : What???s in Store in Q4 Earnings? Yahoo Finance - Mar 7, 2017 Catalyst Pharmaceuticals, Inc. CPRX is expected to report fourth-quarter 2016 results this month. Last quarter, the company recorded a positive earnings surprise of 16.67%.Catalyst Pharmaceutical Partners, Inc.  Broker Price Targets For The ... - Fiscal Standard'
p5
aS'Investor Chatter: Tracking Technical Indicators for Catalyst Pharmaceuticals ... Midway Monitor - 8 hours ago Traders are taking a second look at how shares of Catalyst Pharmaceuticals Inc  have been performing lately. A favorite tool among technical stock analysts is the moving average.'
p6
aS'The Catalyst Pharmaceuticals Inc  PT Set at $3.00 by Roth Capital Petro Global News 24 - Mar 21, 2017 Catalyst Pharmaceuticals Inc  received a $3.00 price target from equities research analysts at Roth Capital in a research report issued to clients and investors on Monday.Catalyst Pharmaceuticals Inc  Upgraded to Buy at Zacks Investment Research - The Cerbat GemCatalyst Pharmaceuticals Inc  PT Set at $3.00 by Roth Capital - Chaffey Breeze'
p7
aS'Catalyst Pharmaceuticals Inc  Jumps Higher For Week Business Review - 13 hours ago Pushing higher over the last five sessions are shares of Catalyst Pharmaceuticals Inc . The stock has risen 45.30% over that span, yielding profits for savvy traders.'
p8
aS'Analytical Guide for New York Community Bancorp, Inc. , Catalyst ... The USA Commerce - Mar 17, 2017 Shares of New York Community Bancorp, Inc.  surged 0.14% to $14.36. During the trading on 03/16/2017. The relative strength index or RSI highlights overbought  and oversold  areas.'
p9
aS'Catalyst Pharmaceuticals Supports Rare Disease Day and Joins Global Movement ... GlobeNewswire  - Feb 27, 2017 CORAL GABLES, Fla., Feb. 27, 2017  -- Catalyst Pharmaceuticals, Inc. ,  a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases&nbsp;...'
p10
a.